Brain and Central Nervous System Tumors — HSPPC-96 Vaccine With Temozolomide in Patients With Newly Diagnosed GBM
Citation(s)
PHASE 2, Multi-center, Single Arm Investigation of HSPPC-96 Vaccine With Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme